All News

The agents that have been evaluated and approved, and those that are coming in the pipeline, make for an exciting time to consider directed therapies.

This week’s recommendation by the Biden administration for booster shots to combat COVID-19 is a call to action for pharmacists to get ready for the upcoming flurry of activity.

Expanding services and revenues for pharmacies while improving public health and reducing stress on parents and others in the health care system is a win-win-win situation.

The study results indicated a nearly 9-fold increase in likelihood of survival without ventilation (SWOV) among this population, compared to a 2.5-fold increased likelihood of SWOV in the overall population.

The investigators concluded that a definite statement on risk or management recommendations cannot be made based on currently published data.

The pharmaceutical market is massive, clocking in at more than $1.2 trillion in 2020, with an anticipated growth of nearly $22 billion dollars expected in 2021. Examining which drug makes up the most of that revenue, one name pulls far away from the competition.

Study indicates that the genetics affecting aggression in children with attention-deficit hyperactivity disorder and disruptive behavior disorders are the same as genetics underlying aggression in the general population.

But state-to-state communications and inconsistencies related to licensing present legal issues.

The lower the glomerular filtration rate, the lower the stage, the worse kidney disease is.

As health care costs rise and cost-sharing increases, treatment-associated expenses will continue to burden patients.

Whereas traditional vaccines have used live or inactivated pathogens to elicit an immune response, mRNA is responsible for cellular processes, building structures, and more.

How would you answer these patients' questions?

The investigators analyzed a panel of antibodies generated in response to the Pfizer COVID-19 vaccine and found that delta was unable to evade all but 1 of the antibodies tested.

In clinical trials, empagliflozin significantly reduced the relative risk of the primary composite endpoint of time to cardiovascular death or hospitalization for heart failure by 25%.

CMS reported that 3.3 million more Medicare Part D beneficiaries with complex health needs than expected between 2013-2018 received a comprehensive medication review as a part of medication therapy management

In the sixth part of the series, students discussed how their involvement in pandemic-related vaccinations or aid efforts affected how they viewed the field and their role in the field.

According to the investigators, both trials demonstrated an overall well-tolerated safety profile for brolucizumab.

Specialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV.

According to Fenn, these numbers are significant when considering the types of errors that are likely to occur in sleep-deprived operators, such as surgeons or police officers, and the 4% decrease in errors could potentially save lives.

It is now the only 4-dose-a-year biologic for psoriasis with options to administer via a single-dose pen or prefilled syringe, the company said.

Severe persistent asthma is the worse type of asthma.

Expectations for pharmacists related to drug utilization reviews lead to examination of woman's death.

Widespread COVID-19 booster shot administration is pending FDA approval and recommendation by the Advisory Committee on Immunization Practices.

A proactive approach can ensure that the patient is getting the right therapy at the right time and the right treatment plan with the least amount of waste.

The continued approval for this indication may be subject upon verification and description of clinical benefit in a confirmatory trial.

Approved by the FDA on June 29, 2020, the pertuzumab, trastuzumab, and hyaluronidase-zzxf combination therapy with chemotherapy offers several advantages to the standard treatment of pertuzumab plus trastuzumab with chemotherapy for breast cancers with HER2 overexpression.

These findings could lead to improved therapies and prolonged survival for patients with metastatic TNBC, according to the study authors.

New roles and responsibilities can be passed to pharmacy technicians in order to free up pharmacists’ time, which enables them to be more engaged with their patients and provide more direct patient care.